Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc

Comment

Peter Sondermann et al. Proc Natl Acad Sci U S A. 2013.

. 2013 Sep 17;110(38):E3547.

doi: 10.1073/pnas.1311721110.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

General mechanism for modulating immunoglobulin effector function.
Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. Sondermann P, et al. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72. doi: 10.1073/pnas.1307864110. Epub 2013 May 22. Proc Natl Acad Sci U S A. 2013. PMID: 23697368 Free PMC article.
Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.
Crispin M, Yu X, Bowden TA. Crispin M, et al. Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3544-6. doi: 10.1073/pnas.1310657110. Epub 2013 Aug 8. Proc Natl Acad Sci U S A. 2013. PMID: 23929778 Free PMC article. No abstract available.

1. Sondermann P, Pincetic A, Maamary J, Lammens K, Ravetch JV. General mechanism for modulating immunoglobulin effector function. Proc Natl Acad Sci USA. 2013;110(24):9868–9872. - PMC - PubMed
1. Crispin M, Yu X, Bowden TA. Crystal structure of sialylated IgG Fc: Implications for the mechanism of intravenous immunoglobulin therapy. Proc Natl Acad Sci USA. 2013;110:E3544–E3546. - PMC - PubMed
1. Krapp S, Mimura Y, Jefferis R, Huber R, Sondermann P. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J Mol Biol. 2003;325(5):979–989. - PubMed
1. Borrok MJ, Jung ST, Kang TH, Monzingo AF, Georgiou G. Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem Biol. 2012;7(9):1596–1602. - PMC - PubMed
1. Barb AW, et al. NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation. Biochemistry. 2012;51(22):4618–4626. - PMC - PubMed